scholarly journals Concerns and perceptions of patients with psoriatic disease during the COVID‐19 pandemic: results from a two‐wave survey by the National Psoriasis Foundation

2021 ◽  
Author(s):  
G.C. Gondo ◽  
S.J. Bell ◽  
J. Slayden ◽  
G. Ullmann ◽  
A. Blauvelt
Keyword(s):  
Psoriatic Disease ◽  
National Psoriasis Foundation

Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey

2020 ◽  
Vol 5 (4) ◽  
pp. 178-183
Author(s):  
George Gondo ◽  
Julia Boles ◽  
Patrick Stone ◽  
Leah Howard ◽  
Stacie J. Bell
Keyword(s):  
Online Survey ◽  
Patient Characteristics ◽  
Insurance Company ◽  
Utilization Management ◽  
Psoriatic Disease ◽  
Management Policies ◽  
National Psoriasis Foundation ◽  
Step Therapy ◽  
To Receive ◽  
Disease Community

Introduction: Utilization management (UM) policies are becoming more common among commercial insurance policies. However, little research has been conducted to understand the prevalence of experiencing UM restrictions among patients with psoriatic disease. Objectives: To understand the prevalence of UM policies within the psoriatic patient community and examine their relationship with patient characteristics. Methods: An online survey of 1205 individuals with a psoriatic disease from the National Psoriasis Foundation’s constituent database was conducted. Data were collected from July 7 to July 31, 2019. The main outcomes of interest for the present study were frequency of experiencing UM policies (eg, prior authorization [PA] or step therapy [ST]) from their insurance company, number, and type of UM policies experienced and relationship between patient characteristics and experiencing these policies. Results: Survey respondents reported high rates of experiencing some form of UM restriction (80.5%). Nearly half (45.1%) of the survey respondents indicated their insurer required them to try a therapy other than the therapy originally prescribed by their physician, a practice known as ST or “fail first” and 73% of respondents reported having to receive PA from their insurer before initiating treatment. Conclusions: Individuals with psoriatic disease commonly encounter UM policies from their insurer when attempting to manage their disease. Statistical analyses suggest that UM policies are related to the type of treatment used by patients and the type of psoriatic disease.

scholarly journals National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1

2020 ◽  
Vol 83 (6) ◽  
pp. 1704-1716 ◽  
Author(s):  
Joel M. Gelfand ◽  
April W. Armstrong ◽  
Stacie Bell ◽  
George L. Anesi ◽  
Andrew Blauvelt ◽  
...  
Keyword(s):  
Task Force ◽  
Psoriatic Disease ◽  
National Psoriasis Foundation

National Psoriasis Foundation: Planning for a Future Free of Psoriatic Disease and Its Burdens

2019 ◽  
Vol 4 (4) ◽  
pp. 177-179
Author(s):  
Leah Howard ◽  
Stacie Bell ◽  
Emily Boyd ◽  
Randy Beranek
Keyword(s):  
Psoriatic Disease ◽  
National Psoriasis Foundation

Incidence of and Risk Factors for Heart Failure in Patients with Psoriatic Disease – A Cohort Study

2021 ◽  
Author(s):  
Sahil Koppikar ◽  
Keith Colaco ◽  
Paula Harvey ◽  
Shadi Akhtari ◽  
Vinod Chandran ◽  
...  
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Cohort Study ◽  
Psoriatic Disease
Sign in / Sign up

Export Citation Format

Share Document